1 October we become SureStone CapitalSame team, same ABN. Our website and email addresses move to surestone.com.au.

ASX Announcements / Mayne Pharma Group Limited (ASX:MYX)

All Mayne Pharma Group Limited (ASX:MYX) announcement summaries, newest first. Every summary is drawn only from the company's official ASX release.

ASX: MYXHealth Care

Mayne Pharma FY26 Revenue $383.7m, EBITDA Down 33%

Mayne Pharma posted unaudited FY26 revenue of $383.7 million, down 6%, with underlying EBITDA of $31.7 million, down 33%, and a 65% FY26 gross margin.

31 Jul, 2026

MYX ASX Announcement Summaries - Ausbiz Capital